It is also worth noting that our comparison with topiramate, which shares a weight loss property, may partly reflect topiramates poor real-world tolerability and compliance rather than a true pharmacological advantage of GLP1 RAs. However, he also stated that the overall signal is encouraging and justifies further investigation

An observational study performed among 303 participants with and without T2DM who underwent computed tomography (CT) angiography due to chest pain, reported a positive association of endogenous GLP-1 levels with coronary plaque burden ( In addition to direct actions in coronary arteries, GLP-1 RAs can prevent the formation and progression of coronary atherosclerosis through indirect mechanisms, such as maintaining glycemic control, losing weight, decreasing systolic blood pressure, obtaining beneficial effects from lipid levels, inhibiting platelet activation, reducing systemic inflammation and levels of circulating BNP ( Glucagon-Like Peptide 1 Receptor Agonists and Vasospasm of Epicardial Coronary Arteries Spasms in the smooth muscle layer of the coronary artery wall can be focal or diffuse, resulting in vasospastic angina or myocardial infarction (MI), respectively
Despite the cost (which is a bit of a stretch for me) it has been totally worth it
Mod GRF 1-29 , also known as CJC-1295 without DAC, is a synthetic analogue of GHRH with four amino acid substitutions that make it resistant to enzymatic degradation while maintaining a short half-life suitable for pulsatile dosing
Constipated for 4 days
Some can stop using them altogether. Indeed, while the weight loss benefits of GLP-1 receptor agonists remain central to their effectiveness against sleep apnea, researchers are increasingly finding that their positive impact on sleep may run deeper